NYSE · CIK 0001956955
UMAC Unusual Machines, Inc.
Insider trading from SEC Form 4. Last filing 7 d ago. Close $19.64 on Oct 12, 2026, +153% from the 52-week low and -42% from the high.
In brief
Unusual Machines, Inc. (UMAC) has 82 SEC Form 4 filings on file from 8 insiders, the latest filed on Oct 6, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 3 open-market sells worth $1.3M, net -$1.3M.
31 open-market trades have been scored at UMAC. The newest: Andrew Ross Camden (President) sold $250k of stock on Aug 20, 2026, filed Aug 21, 2026, scored 28 (weak), under a 10b5-1 plan. The largest of the 31 shown: Andrew Ross Camden (President) sold $3.0M on Jun 4, 2026, scored 70 (notable). 3 insiders sold within 14 days of each other around Aug 20, 2026.
25 Form 144 notices of planned sales are on file, the latest filed Aug 20, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Unusual Machines, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Andrew Ross Camden President sell | $250k 9,625 shares | -4% | +235% from low-24% from high | |
| 31Weak | Brian Joseph Hoff Chief Financial Officer sell | $297k 11,413 shares | -3% | +235% from low-24% from high | |
| 41Moderate | Stacy Rochelle Wright Chief Revenue Officer sell | $715k 27,500 shares | -29% | +235% from low-24% from high | |
| 52Moderate | Jeffrey M Thompson director sell | $816k 30,000 shares | -1% | +310% from low-20% from high | |
| 70Notable | Andrew Ross Camden President sell | $3.0M 100,000 shares | -29% | +395% from low-3% from high | |
| 36Weak | Sanford Rich director sell | $725k 25,000 shares | -12% | +423% from low-9% from high | |
| 52Moderate | Brian Joseph Hoff Chief Financial Officer sell | $2.7M 150,000 shares | -30% | +280% from low-15% from high | |
| 26Weak | Andrew Ross Camden President sell | $136k 9,625 shares | -3% | +207% from low-33% from high | |
| 28Weak | Brian Joseph Hoff Chief Financial Officer sell | $162k 11,412 shares | -2% | +207% from low-33% from high | |
| 10Weak | Sanford Rich director sell | $20k 1,392 shares | -1% | +207% from low-33% from high | |
| 27Weak | Andrew Ross Camden President sell | $179k 9,625 shares | -3% | +295% from low-16% from high | |
| 29Weak | Brian Joseph Hoff Chief Financial Officer sell | $212k 11,413 shares | -2% | +295% from low-16% from high | |
| 10Weak | Sanford Rich director sell | $20k 980 shares | -0% | +295% from low-16% from high | |
| 28Weak | Stacy Rochelle Wright Chief Revenue Officer sell | $255k 13,750 shares | -13% | +295% from low-16% from high | |
| 18Weak | Allan Thomas Evans Chief Executive Officer sell | $22k 11,087 shares | -6% | +147% from low-40% from high | |
| 8Weak | Sanford Rich director sell | $22k 11,087 shares | -5% | +147% from low-40% from high | |
| 51Moderate | Andrew Ross Camden Chief Operating Officer sell | $516k 50,000 shares | -16% | +113% from low-48% from high | |
| 57Moderate | Brian Joseph Hoff Chief Financial Officer sell | $774k 75,000 shares | -15% | +113% from low-48% from high | |
| 24Weak | Andrew Ross Camden Chief Operating Officer sell | $80k 8,750 shares | -3% | +105% from low-60% from high | |
| 23Weak | Cristina Colon director sell | $75k 8,268 shares | -14% | +105% from low-60% from high | |
| 26Weak | Brian Joseph Hoff Chief Financial Officer sell | $80k 8,750 shares | -2% | +105% from low-60% from high | |
| 30Weak | Andrew Ross Camden Chief Operating Officer sell | $443k 43,750 shares | -19% | +592% from low-50% from high | |
| 32Weak | Brian Joseph Hoff Chief Financial Officer sell | $430k 42,500 shares | -10% | +592% from low-50% from high | |
| 38Weak | Andrew Ross Camden Chief Operating Officer sell | $250k 25,000 shares | -14% | +638% from low-47% from high | |
| 18Weak | Andrew Ross Camden Chief Operating Officer sell | $95k 17,500 shares | -9% | +258% from low-74% from high | |
| 20Weak | Brian Joseph Hoff Chief Financial Officer sell | $95k 17,500 shares | -5% | +258% from low-74% from high | |
| 25Weak | Brian Joseph Hoff Chief Financial Officer sell | $478k 83,775 shares | -19% | +323% from low-70% from high | |
| 38Weak | Jeffrey M Thompson director sell | $506k 40,000 shares | -11% | - | |
| 60Notable | Allan Thomas Evans Chief Executive Officer buy | $100k 65,789 shares | +263% | - | |
| 47Moderate | Robert Paul Lowry director buy | $50k 32,895 shares | +81% | - | |
| 50Moderate | Sanford Rich director buy | $100k 65,789 shares | +124% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 20, 2026 | Camden Andrew Ross Officer | 9,625 0.02% of outstanding | $272k | Aug 20, 2026 | $3.1M |
| Aug 20, 2026 | Hoff Brian Joseph Officer | 11,413 0.02% of outstanding | $323k | Aug 20, 2026 | $2.8M |
| Aug 20, 2026 | Wright Stacy Rochelle Officer | 27,500 0.06% of outstanding | $778k | Aug 20, 2026 | none |
| Jun 5, 2026 | Thompson Jeffrey M Director | 30,000 0.06% of outstanding | $969k | Jun 5, 2026 | none |
| Jun 4, 2026 | Camden Andrew Ross Officer | 100,000 0.21% of outstanding | $3.0M | Jun 4, 2026 | $314k |
| Jun 1, 2026 | Rich Sanford Officer | 25,000 0.05% of outstanding | $795k | Jun 1, 2026 | $39k |
| May 29, 2026 | Allan Evans Officer and Director | 500,000 1.05% of outstanding | $15M | May 28, 2026 | none |
| May 27, 2026 | Hoff Brian Joseph Officer | 150,000 0.31% of outstanding | $2.6M | May 27, 2026 | $374k |
| May 21, 2026 | Camden Andrew Ross Officer | 9,625 0.02% of outstanding | $138k | May 21, 2026 | $178k |
| May 21, 2026 | Hoff Brian Joseph Officer | 11,412 0.02% of outstanding | $164k | May 21, 2026 | $212k |
| May 21, 2026 | Rich Sanford Officer | 1,392 0.00% of outstanding | $20k | Mar 16, 2026 | $20k |
| Mar 16, 2026 | Camden Andrew Ross Officer | 9,625 0.02% of outstanding | $213k | Mar 16, 2026 | none |
| Mar 16, 2026 | Hoff Brian Joseph Officer | 11,413 0.03% of outstanding | $253k | Mar 16, 2026 | none |
| Mar 16, 2026 | Rich Sanford Officer | 980 0.00% of outstanding | $20k | Mar 16, 2026 | none |
| Mar 16, 2026 | Wright Stacy Rochelle Officer | 13,750 0.04% of outstanding | $305k | Mar 16, 2026 | none |
| Dec 12, 2025 | Camden Andrew Ross Officer | 50,000 0.13% of outstanding | $544k | Dec 12, 2025 | $80k |
| Dec 12, 2025 | Hoff Brian Joseph Officer | 75,000 0.20% of outstanding | $816k | Dec 12, 2025 | $80k |
| Nov 20, 2025 | Camden Andrew Ross Officer | 8,750 0.02% of outstanding | $78k | Nov 20, 2025 | $442k |
| Nov 20, 2025 | Colon Cristina Director | 10,000 0.03% of outstanding | $91k | Nov 20, 2025 | none |
| Nov 20, 2025 | Hoff Brian Joseph Officer | 8,750 0.02% of outstanding | $78k | Nov 20, 2025 | $429k |
| Aug 20, 2025 | Camden Andrew Ross Officer | 43,750 0.14% of outstanding | $432k | Aug 20, 2025 | $345k |
| Aug 20, 2025 | Hoff Brian Joseph Officer | 42,500 0.14% of outstanding | $420k | Aug 20, 2025 | $570k |
| Jun 16, 2025 | Camden Andrew Ross Officer | 25,000 0.10% of outstanding | $250k | Jun 16, 2025 | $95k |
| May 20, 2025 | Camden Andrew Ross Officer | 17,500 0.07% of outstanding | $95k | May 20, 2025 | none |
| May 20, 2025 | Hoff Brian Joseph Officer | 17,500 0.70% of outstanding | $95k | May 20, 2025 | $475k |
Transactions
The newest 50 of 99 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Allan Thomas Evans Chief Executive Officer | AGrant or award Warrantsderivativeindirect: By 8 Consulting LLC | +5,000,000 | - | - | 5,000,000 | 7 d ago |
| Aug 20, 2026 | Stacy Rochelle Wright Chief Revenue Officer | SOpen-market sale Common Stock10b5-1 | -27,500 | $26.00 | $715k | 68,750 | Aug 21, 2026 |
| Aug 20, 2026 | Brian Joseph Hoff Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -11,413 | $26.01 | $297k | 341,237 | Aug 21, 2026 |
| Aug 20, 2026 | Andrew Ross Camden President | SOpen-market sale Common Stock10b5-1 | -9,625 | $26.01 | $250k | 237,125 | Aug 21, 2026 |
| Jul 24, 2026 | Andrew Ross Camden President | AGrant or award Stock Options (Right to Buy)derivative | +525,000 | $0.00 | $0 | 525,000 | Jul 28, 2026 |
| Jul 24, 2026 | Brian Joseph Hoff Chief Financial Officer | AGrant or award Stock Options (Right to Buy)derivative | +375,000 | $0.00 | $0 | 375,000 | Jul 28, 2026 |
| Jul 24, 2026 | Stacy Rochelle Wright Chief Revenue Officer | AGrant or award Stock Options (Right to Buy)derivative | +375,000 | $0.00 | $0 | 375,000 | Jul 28, 2026 |
| Jun 5, 2026 | Jeffrey M Thompson director | SOpen-market sale Common Stock | -15,000 | $26.96 | $404k | 4,794,392 | Jun 9, 2026 |
| Jun 8, 2026 | Jeffrey M Thompson director | SOpen-market sale Common Stock | -15,000 | $27.42 | $411k | 4,779,392 | Jun 9, 2026 |
| Jun 4, 2026 | Andrew Ross Camden President | SOpen-market sale Common Stock | -100,000 | $30.05 | $3.0M | 246,750 | Jun 5, 2026 |
| Jun 1, 2026 | Sanford Rich director | SOpen-market sale Common Stock10b5-1 | -25,000 | $28.98 | $725k | 182,317 | Jun 2, 2026 |
| May 28, 2026 | Allan Thomas Evans Chief Executive Officer | JOther Forward sale contract (obligation to sell)derivative | +500,000 | - | - | 1,089,141 | May 29, 2026 |
| May 27, 2026 | Brian Joseph Hoff Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -150,000 | $17.71 | $2.7M | 352,650 | May 29, 2026 |
| May 20, 2026 | Robert Paul Lowry director | AGrant or award Common Stockindirect: By Support Services Group LLC | +2,784 | $0.00 | $0 | 10,193 | May 22, 2026 |
| May 20, 2026 | Sanford Rich director | AGrant or award Common Stock10b5-1 | +2,784 | $0.00 | $0 | 208,709 | May 22, 2026 |
| May 20, 2026 | Jeffrey M Thompson director | AGrant or award Common Stock | +2,784 | $0.00 | $0 | 345,345 | May 22, 2026 |
| May 21, 2026 | Andrew Ross Camden President | SOpen-market sale Common Stock10b5-1 | -9,625 | $14.18 | $136k | 346,750 | May 22, 2026 |
| May 21, 2026 | Brian Joseph Hoff Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -11,412 | $14.17 | $162k | 502,650 | May 22, 2026 |
| May 21, 2026 | Sanford Rich director | SOpen-market sale Common Stock10b5-1 | -1,392 | $14.18 | $20k | 207,317 | May 22, 2026 |
| Mar 16, 2026 | Andrew Ross Camden President | SOpen-market sale Common Stock10b5-1 | -9,625 | $18.57 | $179k | 356,375 | Mar 17, 2026 |
| Mar 16, 2026 | Brian Joseph Hoff Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -11,413 | $18.59 | $212k | 514,062 | Mar 17, 2026 |
| Mar 16, 2026 | Stacy Rochelle Wright Chief Revenue Officer | SOpen-market sale Common Stock10b5-1 | -13,750 | $18.57 | $255k | 96,250 | Mar 17, 2026 |
| Mar 13, 2026 | Robert Paul Lowry director | AGrant or award Common Stockindirect: By Support Services Group LLC | +1,961 | $0.00 | $0 | 7,409 | Mar 17, 2026 |
| Mar 13, 2026 | Sanford Rich director | AGrant or award Common Stock10b5-1 | +1,961 | $0.00 | $0 | 206,905 | Mar 17, 2026 |
| Mar 13, 2026 | Jeffrey M Thompson director | AGrant or award Common Stock | +1,961 | $0.00 | $0 | 342,561 | Mar 17, 2026 |
| Mar 16, 2026 | Sanford Rich director | SOpen-market sale Common Stock10b5-1 | -980 | $20.20 | $20k | 205,925 | Mar 17, 2026 |
| Jan 23, 2026 | Allan Thomas Evans Chief Executive Officer | AGrant or award Common Stockindirect: By: 8 Consulting LLC | +220,000 | $0.00 | $0 | 1,423,650 | Jan 27, 2026 |
| Jan 23, 2026 | Brian Joseph Hoff Chief Financial Officer | AGrant or award Common Stock | +110,000 | $0.00 | $0 | 525,475 | Jan 27, 2026 |
| Jan 23, 2026 | Stacy Rochelle Wright Chief Revenue Officer | AGrant or award Common Stock | +110,000 | $0.00 | $0 | 110,000 | Jan 27, 2026 |
| Jan 23, 2026 | Andrew Ross Camden President | AGrant or award Common Stock | +110,000 | $0.00 | $0 | 366,000 | Jan 26, 2026 |
| Dec 31, 2025 | Robert Paul Lowry director | AGrant or award Common Stockindirect: By Support Services Group LLC | +3,140 | $0.00 | $0 | 5,448 | Jan 5, 2026 |
| Dec 31, 2025 | Jeffrey M Thompson director | AGrant or award Common Stock | +3,140 | $0.00 | $0 | 340,600 | Jan 5, 2026 |
| Dec 31, 2025 | Cristina Colon director | AGrant or award Common Stock | +3,140 | $0.00 | $0 | 55,852 | Jan 5, 2026 |
| Dec 29, 2025 | Allan Thomas Evans Chief Executive Officer | MOption exercise Common Stock | +65,789 | $1.99 | $131k | 176,578 | Dec 31, 2025 |
| Dec 29, 2025 | Robert Paul Lowry director | MOption exercise Common Stock | +32,895 | $1.99 | $65k | 155,635 | Dec 31, 2025 |
| Dec 29, 2025 | Sanford Rich director | MOption exercise Common Stock | +65,789 | $1.99 | $131k | 216,031 | Dec 31, 2025 |
| Dec 29, 2025 | Allan Thomas Evans Chief Executive Officer | SOpen-market sale Common Stock | -11,087 | $1.99 | $22k | 165,491 | Dec 31, 2025 |
| Dec 29, 2025 | Sanford Rich director | SOpen-market sale Common Stock | -11,087 | $1.99 | $22k | 204,944 | Dec 31, 2025 |
| Dec 29, 2025 | Robert Paul Lowry director | MOption exercise Warrantsderivative | -32,895 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 29, 2025 | Sanford Rich director | MOption exercise Warrantsderivative | -65,789 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 29, 2025 | Allan Thomas Evans Chief Executive Officer | MOption exercise Warrantsderivative | -65,789 | $0.00 | $0 | 0 | Dec 31, 2025 |
| Dec 12, 2025 | Andrew Ross Camden Chief Operating Officer | SOpen-market sale Common Stock | -50,000 | $10.32 | $516k | 256,000 | Dec 15, 2025 |
| Dec 12, 2025 | Brian Joseph Hoff Chief Financial Officer | SOpen-market sale Common Stock | -75,000 | $10.31 | $774k | 415,475 | Dec 15, 2025 |
| Nov 20, 2025 | Andrew Ross Camden Chief Operating Officer | AGrant or award Common Stock10b5-1 | +125,000 | $0.00 | $0 | 314,750 | Nov 21, 2025 |
| Nov 20, 2025 | Cristina Colon director | SOpen-market sale Common Stock10b5-1 | -8,268 | $9.06 | $75k | 52,712 | Nov 21, 2025 |
| Nov 20, 2025 | Allan Thomas Evans Chief Executive Officer | AGrant or award Common Stockindirect: By: 8 Consulting LLC | +250,000 | $0.00 | $0 | 1,203,650 | Nov 21, 2025 |
| Nov 20, 2025 | Brian Joseph Hoff Chief Financial Officer | AGrant or award Common Stock10b5-1 | +125,000 | $0.00 | $0 | 499,225 | Nov 21, 2025 |
| Nov 20, 2025 | Andrew Ross Camden Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -8,750 | $9.10 | $80k | 306,000 | Nov 21, 2025 |
| Nov 20, 2025 | Brian Joseph Hoff Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -8,750 | $9.10 | $80k | 490,475 | Nov 21, 2025 |
| Aug 20, 2025 | Andrew Ross Camden Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -8,750 | $9.80 | $86k | 224,750 | Aug 22, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Andrew Ross CamdenPresident
- Cristina Colondirector
- Allan Thomas EvansChief Executive Officer
- Brian Joseph HoffChief Financial Officer
- Robert Paul Lowrydirector
- Sanford Richdirector
- Jeffrey M Thompsonceo, chair, officer, director, owner
- Stacy Rochelle WrightChief Revenue Officer
Questions about UMAC
Answered from the filings on this page, as of the latest one.
Are insiders buying UMAC?
As of Oct 6, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 3 open-market sells worth $1.3M by 3 insiders at Unusual Machines, Inc. in the last 90 days, net -$1.3M. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade UMAC on the open market?
Andrew Ross Camden (President) sold $250k of UMAC on Aug 20, 2026 and filed the Form 4 on Aug 21, 2026. InsiderTell scored 28 (weak), under a 10b5-1 plan, with 3 insiders on the same side within 14 days.
How many insiders file Form 4 at Unusual Machines, Inc.?
8 people have filed a Form 4 at Unusual Machines, Inc., among them Andrew Ross Camden (President), Cristina Colon (director), Allan Thomas Evans (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.